Phio Pharmaceuticals Corp.
PHIO· Nasdaq
PHIOPhio Pharmaceuticals Corp.
Filed Mar 22, 2023 · 10-K · 81 days after period end · 0001683168-23-001678
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$2.73M | -$3.45M | -$2.46M | -$2.66M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 22, 2023 · 81 d after period end
